Good evening :)
Place Order
Add to Watchlist

Par Drugs and Chemicals Ltd

PAR Share Price

94.290.01% (-0.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹116 cr, stock is ranked 2,954

High Risk

Stock is 4.50x as volatile as Nifty

PAR Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹116 cr, stock is ranked 2,954

High Risk

Stock is 4.50x as volatile as Nifty

PAR Performance & Key Metrics

PAR Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
8.681.35—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.686.410.79%

PAR Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

PAR Company Profile

Par Drugs and Chemicals provides generic drugs. The Company is engaged in the development and manufacturing of Active Pharma Ingredients (APIs) for the domestic market, as well as for exports to international markets

PAR Similar Stocks (Peers)

Compare with peers Compare with peers 

PAR Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
36.71
36.71
1Y Return
5.71%
5.71%
Buy Reco %
87.10
87.10
Cipla Ltd
CIPLA
PE Ratio
22.75
22.75
1Y Return
1.39%
1.39%
Buy Reco %
73.33
73.33
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
58.69
58.69
1Y Return
12.03%
12.03%
Buy Reco %
70.83
70.83
Mankind Pharma Ltd
MANKIND
PE Ratio
53.44
53.44
1Y Return
21.78%
21.78%
Buy Reco %
81.25
81.25
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
18.46
18.46
1Y Return
4.87%
4.87%
Buy Reco %
50.00
50.00
Compare with Peers

PAR Forecast

PAR Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

PAR

PAR

Income

Balance Sheet

Cash Flow

PAR Income Statement

PAR Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 13.01%, vs industry avg of 10.1%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.02%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 22.85%, vs industry avg of 20.04%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue48.8142.4246.4255.9462.9375.2595.9995.88103.12103.12
Raw Materialssubtract19.5917.9419.2222.1922.0929.6141.0333.3281.4781.47
Power & Fuel Costsubtract8.456.948.9010.709.8213.4917.8316.40
Employee Costsubtract1.842.043.644.113.984.104.895.50
Selling & Administrative Expensessubtract3.302.811.974.585.628.229.6010.16
Operating & Other expensessubtract7.134.674.394.813.233.404.207.44
Depreciation/Amortizationsubtract2.823.143.042.762.823.283.233.443.653.64
Interest & Other Itemssubtract2.502.331.960.790.640.450.130.110.080.08
Taxes & Other Itemssubtract1.341.060.781.233.113.493.755.024.574.56
EPS1.701.381.752.244.724.999.2111.7810.8610.87
DPS0.000.000.001.250.000.000.000.000.000.00
Payout ratio0.000.000.000.560.000.000.000.000.000.00
See Costs

PAR Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2023FY 2023

Annual Report Pending

Investor Presentation

Jun 26PDF
Jun 1PDF
Feb 20PDF
+3 more
FY 2022FY 2022

Annual Report Unavailable

Investor Presentation

May 14PDF
Feb 10PDF
Dec 15PDF
Nov 16PDF
 

PAR Stock Peers

PAR Past Performance & Peer Comparison

PAR Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation-basic on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Par Drugs and Chemicals Ltd8.691.35—
Sun Pharmaceutical Industries Ltd36.715.530.96%
Cipla Ltd22.753.831.08%
Torrent Pharmaceuticals Ltd58.6914.780.18%

PAR Stock Price Comparison

Compare PAR with any stock or ETF
Compare PAR with any stock or ETF
PAR
Loading...

PAR Holdings

PAR Shareholdings

PAR Promoter Holdings Trend

PAR Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

PAR Institutional Holdings Trend

PAR Institutional Holdings Trend

Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 2.24%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

PAR Shareholding Pattern

PAR Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding73.37%0.00%0.00%0.00%26.63%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

PAR Shareholding History

PAR Shareholding History

Dec '23MarJunSepDec '24Mar0.07%0.07%0.32%0.09%0.00%0.00%

PAR Insider Trades & Bulk Stock Deals

PAR Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing PAR stock

smallcases containing PAR stock

Looks like this stock is not in any smallcase yet.

PAR Events

PAR Events

PAR Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

PAR has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

PAR Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

PAR has not given any dividends in last 5 years

PAR Upcoming Dividends

PAR Upcoming Dividends

No upcoming dividends are available

PAR Past Dividends

PAR Past Dividends

Cash Dividend

Ex DateEx DateNov 22, 2021

Interim
Interim | Div/Share: ₹1.25

Dividend/Share

₹1.25

Ex DateEx Date

Nov 22, 2021

Cash Dividend

Ex DateEx DateJul 10, 2020

Final
Final | Div/Share: ₹1.25

Dividend/Share

₹1.25

Ex DateEx Date

Jul 10, 2020

Cash Dividend

Ex DateEx DateNov 22, 2019

Interim
Interim | Div/Share: ₹1.25

Dividend/Share

₹1.25

Ex DateEx Date

Nov 22, 2019

PAR Stock News & Opinions

PAR Stock News & Opinions

Earnings
Par Drugs & Chemicals standalone net profit declines 55.65% in the March 2025 quarter

Net profit of Par Drugs & Chemicals declined 55.65% to Rs 1.65 crore in the quarter ended March 2025 as against Rs 3.72 crore during the previous quarter ended March 2024. Sales declined 2.15% to Rs 22.33 crore in the quarter ended March 2025 as against Rs 22.82 crore during the previous quarter ended March 2024. For the full year,net profit declined 7.86% to Rs 13.36 crore in the year ended March 2025 as against Rs 14.50 crore during the previous year ended March 2024. Sales rose 5.57% to Rs 100.97 crore in the year ended March 2025 as against Rs 95.64 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales22.3322.82 -2 100.9795.64 6 OPM %10.8826.73 -19.3223.87 - PBDT3.206.00 -47 21.5822.96 -6 PBT2.285.11 -55 17.9319.52 -8 NP1.653.72 -56 13.3614.50 -8 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Par Drugs & Chemicals announces board meeting date

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 8 May 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Par Drugs & Chemicals standalone net profit declines 83.04% in the December 2024 quarter

Net profit of Par Drugs & Chemicals declined 83.04% to Rs 0.58 crore in the quarter ended December 2024 as against Rs 3.42 crore during the previous quarter ended December 2023. Sales declined 10.92% to Rs 21.38 crore in the quarter ended December 2024 as against Rs 24.00 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales21.3824.00 -11 OPM %6.6421.79 - PBDT1.685.44 -69 PBT0.774.57 -83 NP0.583.42 -83 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Par Drugs & Chemicals to hold board meeting

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Par Drugs & Chemicals to conduct EGM

Par Drugs & Chemicals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Par Drugs & Chemicals to conduct EGM

Par Drugs & Chemicals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 5 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Par Drugs & Chemicals to conduct board meeting

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 11 January 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Par Drugs & Chemicals to convene EGM

Par Drugs & Chemicals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 31 December 2024 .Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Par Drugs & Chemicals to convene board meeting

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 2 December 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Par Drugs & Chemicals standalone net profit rises 75.87% in the September 2024 quarter

Net profit of Par Drugs & Chemicals rose 75.87% to Rs 8.60 crore in the quarter ended September 2024 as against Rs 4.89 crore during the previous quarter ended September 2023. Sales rose 33.87% to Rs 34.66 crore in the quarter ended September 2024 as against Rs 25.89 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales34.6625.89 34 OPM %32.9228.47 - PBDT12.407.39 68 PBT11.496.54 76 NP8.604.89 76 Powered by Capital Market - Live

8 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Par Drugs and Chemicals Ltd (PAR) today?

    The share price of PAR as on 11th July 2025 is ₹94.29. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Par Drugs and Chemicals Ltd (PAR) share?

    The past returns of Par Drugs and Chemicals Ltd (PAR) share are
    • Past 1 week: -2.57%
    • Past 1 month: -1.77%
    • Past 3 months: -1.77%
    • Past 6 months: -48.39%
    • Past 1 year: -60.27%
    • Past 3 years: -47.15%
    • Past 5 years: -34.02%

  3. What are the peers or stocks similar to Par Drugs and Chemicals Ltd (PAR)?

    The peers or stocks similar to Par Drugs and Chemicals Ltd (PAR) include:

  4. What is the market cap of Par Drugs and Chemicals Ltd (PAR) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Par Drugs and Chemicals Ltd (PAR) is ₹116.02 Cr as of 11th July 2025.

  5. What is the 52 week high and low of Par Drugs and Chemicals Ltd (PAR) share?

    The 52-week high of Par Drugs and Chemicals Ltd (PAR) is ₹348.45 and the 52-week low is ₹81.01.

  6. What is the PE and PB ratio of Par Drugs and Chemicals Ltd (PAR) stock?

    The P/E (price-to-earnings) ratio of Par Drugs and Chemicals Ltd (PAR) is 8.69. The P/B (price-to-book) ratio is 1.35.

  7. Which sector does Par Drugs and Chemicals Ltd (PAR) belong to?

    Par Drugs and Chemicals Ltd (PAR) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Par Drugs and Chemicals Ltd (PAR) shares?

    You can directly buy Par Drugs and Chemicals Ltd (PAR) shares on Tickertape. Simply sign up, connect your demat account and place your order.